We have developed a novel dual-window approach for spectroscopic optical coherence tomography (OCT) measurements and applied it to probe nuclear morphology in tissue samples drawn from the hamster cheek pouch carcinogenesis model. The dual-window approach enables high spectral and depth resolution simultaneously, allowing detection of spectral oscillations, which we isolate to determine the structure of cell nuclei in the basal layer of the epithelium. The measurements were executed with our parallel frequency domain OCT system, which uses light from a thermal source, providing high bandwidth and access to the visible portion of the spectrum. The structural measurements show a highly statistically significant difference between untreated (normal) and treated (hyperplastic/dysplastic) tissues, indicating the potential utility of this approach as a diagnostic method.
The generation of spectroscopic optical coherence tomography (SOCT) signals suffers from an inherent trade off between spatial and spectral resolution. Here, we present a dual window (DW) method that uses two Gaussian windows to simultaneously obtain high spectral and spatial resolution. We show that the DW method probes the Winger time-frequency distribution (TFD) with two orthogonal windows set by the standard deviation of the Gaussian windows used for processing. We also show that in the limit of an infinitesimally narrow window, combined with a large window, this method is equivalent to the Kirkwood & Richaczek TFD and, if the real part is taken, it is equivalent to the Margenau & Hill (MH) TFD. We demonstrate the effectiveness of the method by simulating a signal with four components separated in depth or center frequency. Six TFD are compared: the ideal, the Wigner, the MH, narrow window short time Fourier transform (STFT), wide window STFT, and the DW. The results show that the DW method contains features of the Wigner TFD, and that it contains the highest spatial and spectral resolution that is free of artifacts. This method can enable powerful applications, including accurate acquisition of the spectral information for cancer diagnosis.
Fourier Domain Low Coherence Interferometry (fLCI) is an optical technique that recovers depth-resolved
spectroscopic information about scatterers. The current fLCI system utilizes a white light Xe arc lamp source, a 4-f
interferometer, and an imaging spectrometer at the detection plane to acquire spectra from 256 adjacent spatial
points. This configuration permits the acquisition of ultrahigh depth resolution Fourier domain OCT images without
the need for any beam scanning. fLCI has traditionally obtained depth-resolved spectral information by performing
a short-time Fourier transform (STFT) on the detected spectra, similar to the processing techniques of spectroscopic
OCT. We now employ a dual Gaussian window processing method which simultaneously obtains high spectral and
temporal resolution, thus avoiding the resolution trade-off normally associated with the STFT. Wavelength
dependent variations in scattering intensity are analyzed as a function of depth to obtain structural information about
the probed scatterers.
We now verify fLCI's ability to distinguish between normal and dysplastic epithelial tissue using the
hamster cheek pouch model. Thirty hamsters will have one cheek pouch treated with the known carcinogen DMBA.
At the conclusion of the 24 week treatment period the animals will be anesthetized and the cheek pouches will be
extracted. We will use the fLCI optical system to measure the neoplastic transformation of the in situ subsurface
tissue layers in both the normal and DMBA-treated cheek pouches. Traditional histological analysis will be used to
verify the fLCI measurements. Our results will further establish fLCI as an effective method for distinguishing
between normal and dysplastic epithelial tissues.
Fourier Domain Low Coherence Interferometry (fLCI) is a promising technique which combines the depth
resolution of low coherence interferometry with the sensitivity of light scattering spectroscopy for probing the health
of epithelial tissue layers. Our new fLCI system configuration utilizes a white light Xe arc lamp source and a 4-f
interferometer which re-images light scattered from the sample onto the detection plane. The system employs an
imaging spectrometer at the detection plane to acquire depth resolved profiles from 252 adjacent spatial points
without the need for any scanning. The limited spatial coherence of the light source requires the resolution of
adjacent spatial points for the generation of depth information. Depth-resolved spectral information is recovered by
performing a short-time Fourier transform on the detected spectra, similar to spectroscopic optical coherence
tomography. Wavelength dependent variations in scattering intensity are analyzed as a function of depth to obtain
information about the neoplastic transformation of the probed cells.
Previous studies have demonstrated fLCI as an excellent technique for probing the scatterer morphology of
simple phantoms and of in vitro cancer cell monolayers. We now seek to assess the ability of the new fLCI system
to measure the health of subsurface tissue layers using the hamster cheek pouch model. Seven hamsters will have
one cheek pouch treated with the known carcinogen DMBA. At the conclusion of the 24 week treatment period the
animals will be anesthetized and the cheek pouches will be extracted. We will use the fLCI optical system to
measure the neoplastic transformation of the in situ subsurface tissue layers in both the normal and DMBA-treated
cheek pouches. Traditional histological analysis will be used to verify the fLCI measurements. We expect our
results to establish the feasibility of fLCI to distinguish between healthy and dysplastic epithelial tissues in the
hamster cheek pouch.
Fourier domain low coherence interferometry (fLCI) is an optical technique which combines the depth
resolution of low coherence interferometry with the sensitivity of light scattering spectroscopy. The fLCI system
uses a white light source in a modified Michelson interferometer with a spectrograph for detection of the mixed
signal and reference fields. Depth-resolved structural information is recovered by performing a short-time Fourier
transform on the detected spectrum, similar to spectroscopic optical coherence tomography, and analyzing the
wavelength dependent variations in scattered light as a function of depth. fLCI has been demonstrated as an
excellent technique for probing the nuclear morphology of a monolayer of in vitro cancer cells.
We have built a new fLCI optical system which implements an imaging spectrograph for detection and a 4-
F interferometer which uses a 4-F imaging system to re-image light scattered from the experimental sample onto the
slit of the imaging spectrograph. The new system has allowed us to measure light scattered from the deepest layers
of thick scattering samples, such as tissue phantoms and thick animal tissues, for the first time. We now take the
first steps to quantitatively determine the diameter of scatterers within a thick experimental sample using the new
fLCI system along with the fLCI data processing technique.
Angle-resolved low-coherence interferometry (a/LCI) is used to obtain quantitative, depth-resolved nuclear morphology measurements. We compare the average diameter and texture of cell nuclei in rat esophagus epithelial tissue to grading criteria established in a previous a/LCI study to prospectively grade neoplastic progression. We exploit the depth resolution of a/LCI to exclusively examine the basal layer of the epithelium, approximately 50 to 100 µm beneath the tissue surface, without the need for exogenous contrast agents, tissue sectioning, or fixation. The results of two studies are presented that compare the performance of two a/LCI modalities. Overall, the combined studies show 91% sensitivity and 97% specificity for detecting dysplasia, using histopathology as the standard. In addition, the studies enable the effects of dietary chemopreventive agents, difluoromethylornithine (DFMO) and curcumin, to be assessed by observing modulation in the incidence of neoplastic change. We demonstrate that a/LCI is highly effective for monitoring neoplastic change and can be applied to assessing the efficacy of chemopreventive agents in the rat esophagus.
We have developed Fourier domain low coherence interferometry (fLCI), a novel optical interferometry method for obtaining depth-resolved spectral information, specifically for the purpose of determining the size of scatterers by measuring their elastic scattering properties. The optical system achieves depth resolution by using coherence gating, enabled by the use of a white light source in a Michelson interferometer and detection of the mixed signal and reference fields with a spectrograph. The measured spectrum is Fourier transformed to obtain the axial spatial cross-correlation between the signal and reference fields providing depth-resolution. The spectral dependence of scattering by the sample is determined by windowing the spectrum to measure the scattering amplitude as a function of wavenumber (k = 2 Pi / lambda, where lambda is the wavelength). We present a new common path confgiuration fLCI optical system and demonstrate its capabilities by presenting results which determine the size of cell nuclei in a monolayer of T84 epithelial cells.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.